TrialNature communications2019

Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer.

Sunwang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.